Evidence map›Paper›PMID 38676741›Full record

SynthesisArchives of gynecology and obstetrics2024

Levothyroxine for subclinical hypothyroidism during pregnancy: an updated systematic review and meta-analysis of randomized controlled trials.

Henrique Provinciatto, Marcus Vinicius Barbosa Moreira, Gabriel Rezende Neves, Lucas Rezende De Freitas, Henrique Costa Mitsui, Julio Min Fei Zhang, Edward Araujo Júnior

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Henrique ProvinciattoDepartment of Medicine, Barão de Mauá University Center, Ribeirão Preto, SP, Brazil.
Marcus Vinicius Barbosa MoreiraDepartment of Medicine, University Potiguar (UnP), Natal, RN, Brazil.
Gabriel Rezende NevesDepartment of Medicine, State University of Pará (UEPA), Belém, PA, Brazil.
Lucas Rezende De FreitasDepartment of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, MG, Brazil.
Henrique Costa MitsuiDepartment of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, MG, Brazil.
Julio Min Fei ZhangDepartment of Medicine, University of São Paulo Medical School (USP), São Paulo, SP, Brazil.
Edward Araujo JúniorDepartment of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), Rua Belchior de Azevedo, 156 Apto. 111 Torre Vitoria, São Paulo, SP, 05089-030, Brazil. araujojred@terra.com.br.ORCID http://orcid.org/0000-0002-6145-2532
Universidade Federal de Juiz de Fora · BRCentro Universitário Barão de Mauá · BRUniversidade de São Paulo · BRUniversidade do Estado do Pará · BRUniversidade Municipal de São Caetano do Sul · BRUniversidade Potiguar · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to perform a systematic review and meta-analysis addressing the efficacy of levothyroxine therapy in pregnant women with subclinical hypothyroidism considering most recent evidence and subgroups of interest for clinical practice.

methodsPubMed, Embase, and Cochrane Central were searched from inception for randomized controlled trials (RCTs) comparing levothyroxine with placebo or no intervention in pregnant women with subclinical hypothyroidism. We used a random-effects model and conducted subgroup analyses based on thyroid peroxidase antibody status, thyroid stimulating hormone levels, fertility treatment, and recurrent miscarriage.

resultsWe included 11 RCTs comprising 2,749 pregnant women with subclinical hypothyroidism. Patients treated with levothyroxine (1,439; 52.3%) had significantly lower risk of pregnancy loss (risk ratio 0.69; 95% confidence interval 0.52-0.91; p < 0.01; 6 studies). However, there was no significant association between levothyroxine and live birth (risk ratio 1.01; 95% confidence interval 0.99-1.03; p = 0.29; 8 studies). No statistically significant interaction was observed across subgroups (p > 0.05).

conclusionLevothyroxine replacement therapy for subclinical hypothyroidism during pregnancy may decrease pregnancy loss when early prescribed. Nevertheless, further investigation is needed in patients with thyroid stimulating hormone above four milliunits per liter, especially when associated with recurrent miscarriage or infertility.

Indexed as

HypothyroidismPregnancy ComplicationsRandomized Controlled Trials as TopicThyroxineAbortion, HabitualFemaleHumansPregnancyThyrotropinThyrotropinThyroxinePregnancyRecurrent miscarriageSubclinical hypothyroidismThyroid autoimmunityThyroid peroxidase antibody

Identifiers

PMID38676741
OpenAlexW4395691222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.